AzTrials
AzTrials

Dental ErosionNCT04208802

Effect of Smoking on Saliva Composition and the Development of Dental Erosion

An observational study of Dental Erosion, run by University of Göttingen at 1 site in Germany.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate whether smoking is associated with changes in salivary composition and/or predisposition to erosion. Healthy volunteers are observationally wearing an intraoral device with both bovine tooth specimens (enamel and dentin) and resin specimens twice for two hours each. Read more about this study

Who is it for?
Ages 20 to 50 yearsHealthy volunteers can take part
Conditions the study is for
Dental Erosion
What is being tested?
Use of fluoridated toothpaste, Wearing of an intraoral device with bovine tooth samples and Wearing of an intraoral device with resin samples
How many people
50 participants
Where
1 siteGermany
Study dates
24 Sep 2020to 29 Jul 2022
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 50 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Study population: Exploratory study

Who may be able to join

  • Volunteers aged between 20 and 50 years who are able to give written consent

Who cannot join

  • Non-fulfillment of the inclusion criteria
  • Intake of medications or diseases altering salivary secretion
  • Refusal to use fluoridated toothpastes
  • Known allergies to substances used in the study
  • Orthodontic treatment or malfunction which does not allow wearing an intraoral device

Trial locations and contacts

1 site in 1 country.

Germany1 site
  • University Medical Center Göttingen, Dept. of Preventive Dentistry, Periodontology and Cariology

    Göttingen, Lower Saxony, 37075

Other trials in Germany

About this study

Official title: Effect of Smoking on Saliva Composition and the Development of Dental Erosion - an In-situ Study

The aim of this study is to investigate whether smoking is associated with changes in salivary composition and/or predisposition to erosion.

Healthy volunteers are observationally wearing an intraoral device with both bovine tooth specimens (enamel and dentin) and resin specimens twice for two hours each. Afterwards, specimens are eroded extraorally and calcium release into the acid is measured.

Total protein concentration and protein composition of the salivary pellicles on the resin samples are measured. Additionally, salivary parameters (unstimulated and stimulated saliva flow rate, pH, buffer capacity, total protein content and protein composition as well as concentration of inorganic calcium, phosphate, and fluoride) are measured.

Conditions
Dental Erosion
Being tested
Use of fluoridated toothpaste, Wearing of an intraoral device with bovine tooth samples, Wearing of an intraoral device with resin samples
Medical subject headings
Tooth Erosion

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Use of fluoridated toothpasteOther

    Use of fluoridated toothpaste

  • Wearing of an intraoral device with bovine tooth samplesOther

    Wearing of an intraoral device with bovine tooth samples

  • Wearing of an intraoral device with resin samplesOther

    Wearing of an intraoral device with resin samples

Study groups in NCT04208802
Study groupRoleWhat they receive
SmokersVolunteers smoking at least 10 cigarettes per day
Receives: Other: Use of fluoridated toothpaste; Other: Wearing of an intraoral device with bovine tooth samples; Other: Wearing of an intraoral device with resin samples
Non-smokersNon-smoking volunteers
Receives: Other: Use of fluoridated toothpaste; Other: Wearing of an intraoral device with bovine tooth samples; Other: Wearing of an intraoral device with resin samples

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Calcium release from bovine enamel and dentin specimens by extraoral erosion (nmol/Square Millimeter).

    Measured: Immediately after the intraoral device has been worn once for two hours.

Secondary outcomes (6)
  1. Determination of unstimulated and stimulated saliva flow rate (mL/min).

    Measured: Saliva samples are collected for 5 min each on three visits.

  2. Determination of saliva pH (pH).

    Measured: Saliva samples are collected for 5 min each on three visits.

  3. Determination of salivary buffer capacity (pH).

    Measured: Saliva samples are collected for 5 min each on three visits.

  4. Determination of total protein content (mg/L) and protein composition (qualitatively) in saliva.

    Measured: Saliva samples are collected for 5 min each on three visits.

  5. Determination of inorganic calcium (mmol/L), phosphate (mmol/L) and fluoride (µmol/L) in saliva.

    Measured: Saliva samples are collected for 5 min each on three visits.

  6. Determination of total protein concentration (ng/Square Millimeter) and protein composition (qualitatively) within the salivary pellicles.

    Measured: Immediately after the intraoral device with resin samples has been worn once for two hours.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 Dec 2019
  2. Study start24 Sep 2020
  3. Primary completion29 Jul 2022
  4. Study completion29 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04208802
Sponsor's protocol ID
Erosion-Smoking
Other IDs
15/10/19, 02785
Status last verified
Jan 2026
First submitted
18 Dec 2019
Last updated
27 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Carpenter G, Cotroneo E, Moazzez R, Rojas-Serrano M, Donaldson N, Austin R, Zaidel L, Bartlett D, Proctor G. Composition of enamel pellicle from dental erosion patients. Caries Res. 2014;48(5):361-7. doi: 10.1159/000356973. Epub 2014 Mar 6.

    PubMed 24603346
  • Moazzez R, Bartlett D. Intrinsic causes of erosion. Monogr Oral Sci. 2014;25:180-96. doi: 10.1159/000360369. Epub 2014 Jun 26.

    PubMed 24993266
  • Wiegand A, Bliggenstorfer S, Magalhaes AC, Sener B, Attin T. Impact of the in situ formed salivary pellicle on enamel and dentine erosion induced by different acids. Acta Odontol Scand. 2008 Aug;66(4):225-30. doi: 10.1080/00016350802183401.

    PubMed 18607835
  • Wiegand A, Meier W, Sutter E, Magalhaes AC, Becker K, Roos M, Attin T. Protective effect of different tetrafluorides on erosion of pellicle-free and pellicle-covered enamel and dentine. Caries Res. 2008;42(4):247-54. doi: 10.1159/000135669. Epub 2008 Jun 4.

    PubMed 18523383
  • Zwier N, Huysmans MC, Jager DH, Ruben J, Bronkhorst EM, Truin GJ. Saliva parameters and erosive wear in adolescents. Caries Res. 2013;47(6):548-52. doi: 10.1159/000350361. Epub 2013 Jun 15.

    PubMed 23774653
  • Kanzow P, Wegehaupt FJ, Attin T, Wiegand A. Etiology and pathogenesis of dental erosion. Quintessence Int. 2016 Apr;47(4):275-8. doi: 10.3290/j.qi.a35625.

    PubMed 27022647
  • Wiegand A, Rosemann A, Hoch M, Barke S, Dakna M, Kanzow P. Erosion-Protective Capacity of the Salivary Pellicle of Female and Male Subjects Is Not Different. Caries Res. 2019;53(6):636-642. doi: 10.1159/000500046. Epub 2019 Jun 4.

    PubMed 31163440
  • Kanzow P, Lenz C, Schlarmann F, Barke S, Rohland B, Schmidt A, Gorshkova A, Neuenroth L, Wiegand A. Saliva and salivary pellicle composition and proteomic profile in smokers vs. non-smokers and its effect on dental erosion. J Dent. 2026 Mar;166:106517. doi: 10.1016/j.jdent.2026.106517. Epub 2026 Jan 21.

    PubMed 41577165

Questions about this trial

What is this clinical trial studying?

An observational study of Dental Erosion, run by University of Göttingen at 1 site in Germany.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 27 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Calcium release from bovine enamel and dentin specimens by extraoral erosion (nmol/Square Millimeter). (time frame: Immediately after the intraoral device has been worn once for two hours.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04208802, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 27 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in